Pioneering Study of Alpha-Gal Syndrome Launched at Martha’s Vineyard Hospital

A pioneering study examining Alpha-gal Syndrome (AGS), also known as red meat allergy, is underway at Martha’s Vineyard Hospital. AGS is an allergy transmitted through ticks, with the allergy protein alpha-gal produced in most mammals’ bodies, but not in humans. When bitten by a tick carrying alpha-gal, this substance enters the human bloodstream, causing allergic reactions that can include hives, gastrointestinal issues, breathing difficulties, and in severe cases, anaphylaxis.

These symptoms often occur several hours after consuming red meat or being exposed to other mammal products. The exact number of AGS cases in the U.S. is unknown, with estimates ranging from 100,000 to 450,000 suspected cases between 2010 and 2022. Now, Martha’s Vineyard Hospital is leading the charge in understanding AGS, aiming to enroll up to 300 participants over a two-year period.

Led by Dr. Jacob Lemieux, Dr. Ellen McMahon, and other researchers, the study seeks to uncover who develops AGS after lone star tick exposure, who becomes sensitized without symptoms, and what biological or demographic factors may influence risk. Researchers also plan to identify immune, inflammatory, and other markers that could predict who is most likely to develop the condition.

The study’s lead researcher, Dr. Lemieux, emphasized the emerging health concern on Martha’s Vineyard and the importance of understanding risk factors. "Alpha-gal syndrome is an emerging health concern in our region, but there are still many unanswered questions about why some people develop the condition after a tick bite while others do not," he said.

Participants for the study must be Martha’s Vineyard residents aged 15 or older who have lived on the island for at least three months annually, including pregnant individuals. They will undergo initial and periodic visits, including medical history reviews, blood tests, and other assessments. Dr. McMahon, another lead researcher, highlighted the challenge of diagnosing AGS due to its delayed and varied symptoms.

"This study will help us better understand the patient experience, identify potential warning signs, and improve our ability to support individuals and families affected by this increasingly important health issue," she added. The study aligns with growing concerns about AGS on Martha’s Vineyard, where hospital data shows a surge in alpha-gal testing and local clinicians and biologists observe increasing lone star tick populations.

Martha’s Vineyard's unique setting, with its wildlife population, seasonal shifts, and outdoor environment, makes it an ideal location for studying AGS. Claire Seguin, DNP, president and COO of Martha’s Vineyard Hospital, noted the island's role in understanding the evolution of tick-related health concerns in the community.